Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
ImmuPharma PLC banner

ImmuPharma PLC
LSE:IMM

Watchlist Manager
ImmuPharma PLC Logo
ImmuPharma PLC
LSE:IMM
Watchlist
Price: 6.35 GBX -0.47%
Market Cap: £31.9m
Write Note Create Alert Ask AI

ImmuPharma PLC
Investor Relations

ImmuPharma Plc engages in the research, development, and commercialization of pharmaceutical products. The firm is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The firm has approximately five drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the Company's drug candidate and is a treatment for lupus, and life threatening auto immune disease. The firm's treatment for cancer, IPP-204106, has completed a Phase I/IIa study in cancer patients in France. Its compound IPP-102199 for pain relief is designed as a non-addictive replacement for morphine and other opioids, and is in pre-clinical development. Its treatment for inflammatory and allergic disorders (IPP-201007) is in early stage development. Its compound IPP-203101 is an antibiotic against methicillin-resistant staphylococcus aureus (MRSA) and other infections. The firm's research operations are in France.

Show more
Loading
IMM
FTSE All Share Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Timothy Paul McCarthy XIV, FCCA, M.B.A., MBA
Chairman & CEO
No Bio Available
Dr. Timothy Gary Franklin M.B.A., Ph.D.
COO & Director
No Bio Available
Ms. Lisa Baderoon
Head of Investor Relations & Non Executive Director
No Bio Available
Dr. Jean-Marie Geiger PharmD, MD
Head of Clinical Development
No Bio Available
Dr. Laura Mauran-Ambrosino Ph.D.
Chief Scientific Officer of ImmuPharma Biotech
No Bio Available
Ms. Lara E. Sucheston-Campbell
Head of Clinical & Medical Affairs
No Bio Available

Contacts

Address
London
One Bartholomew Close
Contacts
+442071524080.0
www.immupharma.co.uk
sparklesyt

See Also

Summary
IMM intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMM stock valuation using valuation multiples.
Wall Street Estimates
IMM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.